Physician profile
Stuart R Stoller
NPI 1184665713
$4,500.57
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,856 · 2020: $645.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk As | $1,843.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $492.04 | 2019-2020 | |
| Novo Nordisk INC | $422.29 | 2019-2020 | |
| Amgen INC. | $279.38 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $202.07 | 2019-2020 | |
| Lilly USA, LLC | $198.73 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $195.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $192.42 | 2019-2020 | |
| Pfizer INC. | $180.17 | 2019-2020 | |
| Amarin Pharma, INC. | $138.49 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $71.25 | 2019-2020 | |
| Mylan Specialty L.P. | $49.27 | 2019 | |
| Glaxosmithkline, LLC. | $47.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $46.85 | 2019-2020 | |
| Melinta Therapeutics, LLC | $45.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25.29 | 2019 | |
| Scilex Pharmaceuticals INC. | $23.86 | 2019 | |
| Allergan, INC. | $19.85 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.58 | 2019 | |
| Medicure Pharma INC. | $10.26 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Stoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.